NPA
GILD icon

Nichols & Pratt Advisers’s Gilead Sciences GILD Stock Holding History

Nichols & Pratt Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-45,700
Closed -$2.97M – 92
2019
Q4 		$2.97M Sell
45,700
-37,750
-45% -$2.46M 0.24% 51
2019
Q3 		$5.29M Sell
83,450
-1,283
-2% -$83.9K 0.43% 46
2019
Q2 		$5.73M Sell
84,733
-6,707
-7% -$441K 0.47% 45
2019
Q1 		$5.95M Sell
91,440
-50,921
-36% -$3.38M 0.5% 45
2018
Q4 		$8.92M Sell
142,361
-7,416
-5% -$518K 0.84% 38
2018
Q3 		$11.6M Sell
149,777
-2,290
-2% -$173K 0.96% 37
2018
Q2 		$10.8M Sell
152,067
-2,690
-2% -$190K 0.96% 37
2018
Q1 		$11.6M Sell
154,757
-248
-0.2% -$19.7K 1.06% 35
2017
Q4 		$11.1M Sell
155,005
-1,020
-0.7% -$77.5K 0.97% 37
2017
Q3 		$12.7M Sell
156,025
-3,930
-2% -$301K 1.13% 32
2017
Q2 		$11.3M Sell
159,955
-2,787
-2% -$185K 1.03% 33
2017
Q1 		$11M Buy
162,742
+28,965
+22% +$2.04M 1.02% 32
2016
Q4 		$9.62M Buy
133,777
+493
+0.4% +$36.6K 0.91% 35
2016
Q3 		$10.5M Buy
133,284
+14,083
+12% +$1.14M 0.97% 34
2016
Q2 		$9.96M Buy
119,201
+11,945
+11% +$1.06M 0.9% 35
2016
Q1 		$9.88M Buy
107,256
+14,310
+15% +$1.29M 0.91% 34
2015
Q4 		$9.4M Buy
92,946
+10,718
+13% +$1.12M 0.9% 32
2015
Q3 		$8.07M Buy
82,228
+20,750
+34% +$2.3M 0.81% 38
2015
Q2 		$7.19M Buy
61,478
+4,980
+9% +$544K 0.67% 42
2015
Q1 		$5.54M Buy
56,498
+6,010
+12% +$610K 0.51% 44
2014
Q4 		$4.77M Buy
50,488
+3,015
+6% +$312K 0.42% 46
2014
Q3 		$5.04M Buy
47,473
+1,560
+3% +$153K 0.45% 47
2014
Q2 		$3.83M Buy
45,913
+11,023
+32% +$858K 0.33% 49
2014
Q1 		$2.5M Buy
+34,890
New +$2.74M 0.23% 55

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Nichols & Pratt Advisers's GILD Position: Q1 2020 in Review

Nichols & Pratt Advisers sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 45,700 shares — an estimated $2.97M sold.

Nichols & Pratt Advisers first reported a position in GILD in Q1 2014 and held it in 24 quarters. The position peaked at $12.7M in Q3 2017. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Nichols & Pratt Advisers reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Nichols & Pratt Advisers sold 45,700 Gilead Sciences shares in Q1 2020, an estimated $2.97M.
  • Nichols & Pratt Advisers first reported a position in Gilead Sciences in Q1 2014 and held it in 24 quarters.
  • Nichols & Pratt Advisers's Gilead Sciences position peaked at $12.7M in Q3 2017.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Nichols & Pratt Advisers's 13F filing for Q1 2020, filed 24 Apr 2020.